{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:58:34Z","timestamp":1760266714811},"publisher-location":"Berlin, Heidelberg","reference-count":129,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540297130"},{"type":"electronic","value":"9783540297147"}],"license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006]]},"DOI":"10.1007\/3-540-29714-6_4","type":"book-chapter","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T14:24:44Z","timestamp":1157639084000},"page":"67-88","source":"Crossref","is-referenced-by-count":18,"title":["Sex Hormones and SLE: Influencing the Fate of Autoreactive B Cells"],"prefix":"10.1007","author":[{"given":"J. F. G.","family":"Cohen-Solal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Jeganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Peeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.7326\/0003-4819-122-12-199506150-00009","volume":"122","author":"D.T. Boumpas","year":"1995","unstructured":"Boumpas DT, Austin HA 3rd, Fessler BJ, Balow JE, Klippel JH, Lockshin MD (1995) Systemic lupus erythematosus: emerging concepts. Part 1. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 122:940\u2013950","journal-title":"Ann Intern Med"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"M.R. Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526\u20131533","journal-title":"N Engl J Med"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","volume":"15","author":"E.K. Wakeland","year":"2001","unstructured":"Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397\u2013408","journal-title":"Immunity"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R. Cervera","year":"1993","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72:113\u2013124","journal-title":"Medicine"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/34.9.866","volume":"34","author":"L.B. Tucker","year":"1995","unstructured":"Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 34:866\u2013872","journal-title":"Br J Rheumatol"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/ard.50.10.702","volume":"50","author":"J. Font","year":"1991","unstructured":"Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, Ingelmo M (1991) Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 50:702\u2013705","journal-title":"Ann Rheum Dis"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780300301","volume":"30","author":"R.G. Lahita","year":"1987","unstructured":"Lahita RG, Bradlow HL, Ginzler E, Pang S, New M (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 30:241\u2013248","journal-title":"Arthritis Rheum"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/art.1780221106","volume":"22","author":"R.G. Lahita","year":"1979","unstructured":"Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1979) Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 22:1195\u20131198","journal-title":"Arthritis Rheum"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(68)90216-X","volume":"25","author":"B.L. Pimstone","year":"1968","unstructured":"Pimstone BL (1968) S.L.E. cells after oral contraceptives. Lancet 25:1153","journal-title":"Lancet"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0002-9378(71)90730-7","volume":"110","author":"T.A. Chapel","year":"1971","unstructured":"Chapel TA, Burns RE (1971) Oral contraceptives and exacerbation of lupus erythematosus. Am J Obstet Gynecol 110:366\u2013369","journal-title":"Am J Obstet Gynecol"},{"key":"4_CR11","first-page":"448","volume":"5","author":"R.L. Travers","year":"1978","unstructured":"Travers RL, Hughes GR (1978) Oral contraceptive therapy and systemic lupus erythematosus. J Rheumatol 5:448\u2013451","journal-title":"J Rheumatol"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.1780231213","volume":"23","author":"M. Garovich","year":"1980","unstructured":"Garovich M, Agudelo C, Pisko E (1980) Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 23:1396\u20131398","journal-title":"Arthritis Rheum"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1346-8138.1991.tb03041.x","volume":"18","author":"F. Furukawa","year":"1991","unstructured":"Furukawa F, Tachibana T, Imamura S, Tamura T (1991) Oral contraceptive-induced lupus erythematosus in a Japanese woman. J Dermatol 18:56\u201358","journal-title":"J Dermatol"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/25.3.300","volume":"25","author":"C. Barrett","year":"1986","unstructured":"Barrett C, Neylon N, Snaith ML (1986) Oestrogen-induced systemic lupus erythematosus. Br J Rheumatol 25:300\u2013301","journal-title":"Br J Rheumatol"},{"key":"4_CR15","first-page":"253","volume":"141","author":"P. Jungers","year":"1990","unstructured":"Jungers P, Liote F, Dehaine V, Dougados M, Viriot J, Pelissier C, Kuttenn F (1990) Hormonal contraception and lupus (in French; review). AnnMed Interne (Paris) 141:253\u2013256","journal-title":"AnnMed Interne"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/03009749109096822","volume":"20","author":"H.A. Julkunen","year":"1991","unstructured":"Julkunen HA (1991) Oral contraceptives in systemic lupus erythematosus: sideeffects and influence on the activity of SLE. Scand J Rheumatol 20:427\u2013433","journal-title":"Scand J Rheumatol"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-123-12-199512150-00015","volume":"123","author":"J.P. Buyon","year":"1995","unstructured":"Buyon JP, Belmont HM, Kalunian KC (1995) Postmenopausal hormone therapy and systemic lupus erythematosus. Ann Intern Med 123:961","journal-title":"Ann Intern Med"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339400300104","volume":"3","author":"N.K. Arden","year":"1994","unstructured":"Arden NK, Lloyd ME, Spector TD, Hughes GR (1994) Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE). Lupus 3:11\u201313","journal-title":"Lupus"},{"key":"4_CR19","first-page":"2149","volume":"24","author":"S. Kreidstein","year":"1997","unstructured":"Kreidstein S, Urowitz MB, Gladman DD, Gough J (1997) Hormone replacement therapy in systemic lupus erythematosus. J Rheumatol 24:2149\u20132152","journal-title":"J Rheumatol"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/03009749850154357","volume":"27","author":"C.C. Mok","year":"1998","unstructured":"Mok CC, Lau CS, Ho CT, Lee KW, Mok MY, Wong RW (1998) Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus. Scand J Rheumatol 27:342\u2013346","journal-title":"Scand J Rheumatol"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-122-6-199503150-00005","volume":"122","author":"J. Sanchez-Guerrero","year":"1995","unstructured":"Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA (1995) Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122:430\u2013433","journal-title":"Ann Intern Med"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.1780400505","volume":"40","author":"J. Sanchez-Guerrero","year":"1997","unstructured":"Sanchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA (1997) Use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40:804\u2013808","journal-title":"Arthritis Rheum"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/art.10723","volume":"48","author":"J.P. Buyon","year":"2003","unstructured":"Buyon JP, Petri M, Kim M, Kalunian K, Grossman J, Hahn B, Merrill J, Sammaritano L, Lockshin M, Alarcon G, Manzi S, Belmont H, Sigler L, Dooley M, VonFeldt J, McCune W, Friedman A, Diamond B, Mackay M, Cronin M (2003) Estrogen\/cyclic progesterone replacement is associated with an increased rate of mild\/moderate but not severe flares in SLE patients in the SELENA trial (abstract). Arthritis Rheum 48:3659\u2013660","journal-title":"Arthritis Rheum"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1084\/jem.147.6.1568","volume":"147","author":"J.R. Roubinian","year":"1978","unstructured":"Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK (1978) Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB\/NZW F1 mice. J Exp Med 147:1568\u20131583","journal-title":"J Exp Med"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1990.tb03311.x","volume":"80","author":"H. Carlsten","year":"1990","unstructured":"Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA (1990) Oestrogen is a potent disease accelerator in SLE-prone MRL lpr\/lpr mice. Clin Exp Immunol 80:467\u2013473","journal-title":"Clin Exp Immunol"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0008-8749(92)90236-I","volume":"144","author":"H. Carlsten","year":"1992","unstructured":"Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowski A (1992) Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr\/lpr mice. Cell Immunol 144:190\u2013202","journal-title":"Cell Immunol"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08916934.2002.11873700","volume":"33","author":"Y.Y. Dhaher","year":"2001","unstructured":"Dhaher YY, Greenstein BD, Khamashta MA, Hughes GR (2001) Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb\/C and MRL\/Mp-Lpr\/Lpr mice, a model of systemic lupus erythematosus (SLE). Autoimmunity 33:237\u2013243","journal-title":"Autoimmunity"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI109390","volume":"63","author":"J.R. Roubinian","year":"1979","unstructured":"Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK (1979) Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest 63:902\u2013911","journal-title":"J Clin Invest"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.62.4.341","volume":"62","author":"Z.M. Sthoeger","year":"2003","unstructured":"Sthoeger ZM, Zinger H, Mozes E (2003) Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann RheumDis 62:341\u2013346","journal-title":"Ann RheumDis"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1093\/jn\/133.11.3610","volume":"133","author":"K.J. Auborn","year":"2003","unstructured":"Auborn KJ, Qi M, Yan XJ, Teichberg S, Chen D, Madaio MP, Chiorazzi N (2003) Lifespan is prolonged in autoimmune-prone (NZB\/NZW) F1 mice fed a diet supplemented with indole-3-carbinol. J Nutr 133:3610\u20133613","journal-title":"J Nutr"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/096120339600500107","volume":"5","author":"S.H. Allen","year":"1996","unstructured":"Allen SH, Sharp GC, Wang G, Conley C, Takeda Y, Conroy SE, Walker SE (1996) Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 5:30\u201337","journal-title":"Lupus"},{"key":"4_CR32","first-page":"479","volume":"16","author":"M. Funauchi","year":"1998","unstructured":"Funauchi M, Ikoma S, Enomoto H, Sugiyama M, Ohno M, Hamada K, Kanamaru A (1998) Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma. Clin Exp Rheumatol 16:479\u2013482","journal-title":"Clin Exp Rheumatol"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/clin.1994.1095","volume":"71","author":"R. McMurray","year":"1994","unstructured":"McMurray R, Keisler D, Izui S, Walker SE (1994) Hyperprolactinemia in male NZB\/NZW (B\/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 71:338\u2013343","journal-title":"Clin Immunol Immunopathol"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.147.11.3780","volume":"147","author":"R. McMurray","year":"1991","unstructured":"McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE (1991) Prolactin influences autoimmune disease activity in the female B\/W mouse. J Immunol 147:3780\u20133787","journal-title":"J Immunol"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.185.7.1317","volume":"185","author":"L. Spatz","year":"1997","unstructured":"Spatz L, Saenko V, Iliev A, Jones L, Geskin L, Diamond B (1997) Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determination. J Exp Med 185:1317\u20131326","journal-title":"J Exp Med"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1304::AID-IMMU1304>3.0.CO;2-6","volume":"29","author":"M.S. Bynoe","year":"1999","unstructured":"Bynoe MS, Spatz L, Diamond B (1999) Characterization of anti-DNA B cells that escape negative selection. Eur J Immunol 29:1304\u20131313","journal-title":"Eur J Immunol"},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3168::AID-IMMU3168>3.0.CO;2-H","volume":"29","author":"P. Kuo","year":"1999","unstructured":"Kuo P, Bynoe MS, Wang C, Diamond B (1999) Bcl-2 leads to expression of anti-DNA B cells but no nephritis: a model for a clinical subset. Eur J Immunol 29:3168\u20133178","journal-title":"Eur J Immunol"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1172\/JCI0214873","volume":"109","author":"C.M. Grimaldi","year":"2002","unstructured":"Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B (2002) Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 109:1625\u20131633","journal-title":"J Clin Invest"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI200316530","volume":"111","author":"E. Peeva","year":"2003","unstructured":"Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B (2003) Prolactin modulates the naive B cell repertoire. J Clin Invest 111:275\u2013283","journal-title":"J Clin Invest"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.170.1.114","volume":"170","author":"G. Mor","year":"2003","unstructured":"Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, Muzaffar S, Kohen F (2003) Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114\u2013122","journal-title":"J Immunol"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/cimm.2002.1886","volume":"214","author":"E.M. Curran","year":"2001","unstructured":"Curran EM, Berghaus LJ, Vernetti NJ, Saporita AJ, Lubahn DB, Estes DM (2001) Natural killer cells express estrogen receptor-alpha and estrogen receptor-beta and can respondto estrogen via anon-estrogen receptor-alpha-mediated pathway. Cell Immunol 214:12\u201320","journal-title":"Cell Immunol"},{"key":"4_CR42","first-page":"33","volume":"2","author":"J. Tornwall","year":"1999","unstructured":"Tornwall J, Carey AB, Fox RI, Fox HS (1999) Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. J Gend Specif Med 2:33\u201340","journal-title":"J Gend Specif Med"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra000471","volume":"346","author":"C.J. Gruber","year":"2002","unstructured":"Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346:340\u2013352","journal-title":"N Engl J Med"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(98)00039-8","volume":"422","author":"W.P. Benten","year":"1998","unstructured":"Benten WP, Lieberherr M, Giese G, Wunderlich F (1998) Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 422:349\u2013353","journal-title":"FEBS Lett"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/endo.142.4.8094","volume":"142","author":"W.P. Benten","year":"2001","unstructured":"Benten WP, Stephan C, Lieberherr M, Wunderlich F (2001) Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669\u20131677","journal-title":"Endocrinology"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0039-128X(02)00013-2","volume":"67","author":"W.P. Benten","year":"2002","unstructured":"Benten WP, Stephan C, Wunderlich F (2002) B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids 67:647\u2013654","journal-title":"Steroids"},{"key":"4_CR47","first-page":"307","volume":"13","author":"M. Razandi","year":"1999","unstructured":"Razandi M, Pedram A, Greene GL, Levin ER (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307\u2013319","journal-title":"Mol Endocrinol"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","volume":"307","author":"C.M. Revankar","year":"2005","unstructured":"Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A trans-membrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625\u20131630","journal-title":"Science"},{"key":"4_CR49","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.178.5.1507","volume":"178","author":"K.L. Medina","year":"1993","unstructured":"Medina KL, Smithson G, Kincade PW (1993) Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 178:1507\u20131515","journal-title":"J Exp Med"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/90659","volume":"2","author":"K.L. Medina","year":"2001","unstructured":"Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW (2001) Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2:718\u2013724","journal-title":"Nat Immunol"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0897.1996.tb00176.x","volume":"36","author":"A.G. Rijhsinghani","year":"1996","unstructured":"Rijhsinghani AG, Thompson K, Bhatia SK, Waldschmidt TJ (1996) Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 36:269\u2013277","journal-title":"Am J Reprod Immunol"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/cimm.2000.1719","volume":"205","author":"M.C. Erlandsson","year":"2000","unstructured":"Erlandsson MC, Gomori E, Taube M, Carlsten H (2000) Effects of raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice. Cell Immunol 205:103\u2013109","journal-title":"Cell Immunol"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.156.2.644","volume":"156","author":"L. Krishnan","year":"1996","unstructured":"Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M (1996) Pregnancy impairs resistance of C57BL\/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol 156:644\u2013652","journal-title":"J Immunol"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.4049\/jimmunol.146.12.4362","volume":"146","author":"H.S. Fox","year":"1991","unstructured":"Fox HS, Bond BL, Parslow TG (1991) Estrogen regulates the IFN-gamma promoter. J Immunol 146:4362\u20134367","journal-title":"J Immunol"},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/immu.200310027","volume":"33","author":"A. Maret","year":"2003","unstructured":"Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, Dupont S, Chambon P, Druet P, Bayard F, Guery JC (2003) Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 33:512\u2013521","journal-title":"Eur J Immunol"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcb.10607","volume":"90","author":"G. Carruba","year":"2003","unstructured":"Carruba G, D\u2019Agostino P, Miele M, Calabro M, Barbera C, Bella GD, Milano S, Ferlazzo V, Caruso R, Rosa ML, Cocciadiferro L, Campisi I, Castagnetta L, Cillari E (2003) Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J Cell Biochem 90:187\u2013196","journal-title":"J Cell Biochem"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.20309","volume":"50","author":"P.R. Kramer","year":"2004","unstructured":"Kramer PR, Kramer SF, Guan G (2004) 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 50:1967\u20131975","journal-title":"Arthritis Rheum"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0091-6749(99)70503-8","volume":"103","author":"N. Kanda","year":"1999","unstructured":"Kanda N, Tamaki K (1999) Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 103:282\u2013288","journal-title":"J Allergy Clin Immunol"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/clin.1996.4300","volume":"82","author":"M.J. Evans","year":"1997","unstructured":"Evans MJ, MacLaughlin S, Marvin RD, Abdou NI (1997) Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol 82:258\u2013262","journal-title":"Clin Immunol Immunopathol"},{"key":"4_CR60","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","volume":"148","author":"B.S. Andrews","year":"1978","unstructured":"Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148:1198\u20131215","journal-title":"J Exp Med"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","volume":"37","author":"A.N. Theofilopoulos","year":"1985","unstructured":"Theofilopoulos AN, Dixon FJ (1985) Murine models of systemic lupus erythematosus. Adv Immunol 37:269\u2013390","journal-title":"Adv Immunol"},{"key":"4_CR62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.iy.09.040191.001331","volume":"9","author":"P.L. Cohen","year":"1991","unstructured":"Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243\u2013269","journal-title":"Annu Rev Immunol"},{"key":"4_CR63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1990.tb03311.x","volume":"80","author":"H. Carlsten","year":"1990","unstructured":"Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA (1990) Oestrogen is a potent disease accelerator in SLE-prone MRLl pr\/lpr mice. Clin Exp Immunol 80:467\u2013473","journal-title":"Clin Exp Immunol"},{"key":"4_CR64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.183.2.371","volume":"183","author":"C.C. Yu","year":"1996","unstructured":"Yu CC, Tsui HW, Ngan BY, Shulman MJ, Wu GE, Tsui FW(1996) B and T cells are not required for the viable motheaten phenotype. J Exp Med 183:371\u2013380","journal-title":"J Exp Med"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.4049\/jimmunol.159.6.3024","volume":"159","author":"C.M. Westhoff","year":"1997","unstructured":"Westhoff CM, Whittier A, Kathol S, McHugh J, Zajicek C, Shultz LD, Wylie DE (1997) DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance. J Immunol 159:3024\u20133033","journal-title":"J Immunol"},{"key":"4_CR66","first-page":"179","volume":"116","author":"L.D. Shultz","year":"1984","unstructured":"Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL (1984) \u201cViable motheaten,\u201d a new allele at the motheaten locus. I. Pathology. Am J Pathol 116:179\u2013192","journal-title":"Am J Pathol"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/39.1.18","volume":"39","author":"M.L. Stoll","year":"2000","unstructured":"Stoll ML, Gavalchin J (2000) Systemic lupus erythematosus-messages from experimental models. Rheumatology (Oxford) 39:18\u201327","journal-title":"Rheumatology (Oxford)"},{"key":"4_CR68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0008-8749(92)90236-I","volume":"144","author":"H. Carlsten","year":"1992","unstructured":"Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowski A (1992) Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr\/lpr mice. Cell Immunol 144:190\u2013202","journal-title":"Cell Immunol"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biopha.2004.04.007","volume":"58","author":"E. Peeva","year":"2004","unstructured":"Peeva E, Venkatesh J, Michael D, Diamond B (2004) Prolactin as a modulator of B cell function: implications for SLE. Biomed Pharmacother 58:310\u2013319","journal-title":"Biomed Pharmacother"},{"key":"4_CR70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3181\/00379727-215-44111","volume":"215","author":"L.Y. Yu-Lee","year":"1997","unstructured":"Yu-Lee LY (1997) Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med 215:35\u201352","journal-title":"Proc Soc Exp Biol Med"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1191\/096120301717164949","volume":"10","author":"C.V. Clevenger","year":"2001","unstructured":"Clevenger CV, Kline JB (2001) Prolactin receptor signal transduction. Lupus 10:706\u2013718","journal-title":"Lupus"},{"key":"4_CR72","first-page":"29","volume":"7","author":"P.A. Kelly","year":"1991","unstructured":"Kelly PA, Djiane J, Banville D, Ali S, Edery M, Rozakis M (1991) The growth hormone\/prolactin receptor gene family. Oxf Surv Eukaryot Genes 7:29\u201350","journal-title":"Oxf Surv Eukaryot Genes"},{"key":"4_CR73","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/bi034217s","volume":"42","author":"W. Wu","year":"2003","unstructured":"Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM (2003) Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 42:7561\u20137570","journal-title":"Biochemistry"},{"key":"4_CR74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1677\/joe.0.1680227","volume":"168","author":"L. Yang","year":"2001","unstructured":"Yang L, Kuo CB, Liu Y, Coss D, Xu X, Chen C, Oster-Granite ML, Walker AM (2001) Administration of unmodified prolactin (U-PRL) and a molecular mimic of phosphorylated prolactin (PP-PRL) during rat pregnancy provides evidence that the U-PRL:PP-PRL ratio is crucial to the normal development of pup tissues. J Endocrinol 168:227\u2013238","journal-title":"J Endocrinol"},{"key":"4_CR75","first-page":"583","volume":"10","author":"P. Morales","year":"1999","unstructured":"Morales P, Carretero MV, Geronimo H, Copin SG, Gaspar ML, Marcos MA, Martin-Perez J. (1999) Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ 10:583\u2013590","journal-title":"Cell Growth Differ"},{"key":"4_CR76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/1998\/93086","volume":"5","author":"J. Moreno","year":"1998","unstructured":"Moreno J, Varas A, Vicente A, Zapata AG (1998) Role of prolactin in the recovered T-cell development of early partially decapitated chicken embryo. Dev Immunol 5:183\u2013195","journal-title":"Dev Immunol"},{"key":"4_CR77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2004.11.008","volume":"160","author":"P.C. Carreno","year":"2005","unstructured":"Carreno PC, Sacedon R, Jimenez E, Vicente A, Zapata AG (2005) Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol 160:135\u2013145","journal-title":"J Neuroimmunol"},{"key":"4_CR78","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1210\/endo.139.9.6209","volume":"139","author":"R.W. Steger","year":"1998","unstructured":"Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman ND (1998) Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139:3691\u20133695","journal-title":"Endocrinology"},{"key":"4_CR79","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4049\/jimmunol.163.2.576","volume":"163","author":"B. Bouchard","year":"1999","unstructured":"Bouchard B, Ormandy CJ, Di Santo JP, Kelly PA (1999) Immune system development and function in prolactin receptor-deficient mice. J Immunol 163:576\u2013182","journal-title":"J Immunol"},{"key":"4_CR80","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000126276","volume":"56","author":"C. Sandi","year":"1992","unstructured":"Sandi C, Cambronero JC, Borrell J, Guaza C (1992) Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation. Neuroendocrinology 56:574\u2013581","journal-title":"Neuroendocrinology"},{"key":"4_CR81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1385\/ENDO:9:2:163","volume":"9","author":"J.S. Krumenacker","year":"1998","unstructured":"Krumenacker JS, Buckley DJ, Leff MA, McCormack JT, de Jong G, Gout PW, Reed JC, Miyashita T, Magnuson NS, Buckley AR (1998) Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine 9:163\u2013170","journal-title":"Endocrine"},{"key":"4_CR82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3181\/00379727-205-43683","volume":"205","author":"T.C. Cesario","year":"1994","unstructured":"Cesario TC, Yousefi S, Carandang G, Sadati N, Le J, Vaziri N. (1994) Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proc Soc Exp Biol Med 205:89\u201395","journal-title":"Proc Soc Exp Biol Med"},{"key":"4_CR83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0090-1229(86)90243-6","volume":"38","author":"A. Vidaller","year":"1986","unstructured":"Vidaller A, Llorente L, Larrea F, Mendez JP, Alcocer-Varela J, Alarcon-Segovia D (1986) T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin Immunol Immunopathol 38:337\u2013343","journal-title":"Clin Immunol Immunopathol"},{"key":"4_CR84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF01452255","volume":"17","author":"L.J. Jara","year":"1998","unstructured":"Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR(1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110\u2013114","journal-title":"Clin Rheumatol"},{"key":"4_CR85","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000237242","volume":"109","author":"M.A. Gutierrez","year":"1996","unstructured":"Gutierrez MA, Molina JF, Jara LJ, Garcia C, Gutierrez-Urena S, Cuellar ML, Gharavi A, Espinoza LR (1996) Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 109:229\u2013235","journal-title":"Int Arch Allergy Immunol"},{"key":"4_CR86","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.60.3.242","volume":"60","author":"A.M. Jacobi","year":"2001","unstructured":"Jacobi AM, Rohde W, Volk HD, Dorner T, Burmester GR, Hiepe F (2001) Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis 60:242\u2013247","journal-title":"Ann Rheum Dis"},{"key":"4_CR87","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/rheumatology\/39.6.646","volume":"39","author":"L.G. Ratkay","year":"2000","unstructured":"Ratkay LG, Weinberg J, Waterfield JD (2000) The effect of lactation in the postpartum arthritis of MRL-lpr\/fasmice. Rheumatology (Oxford) 39:646\u2013651","journal-title":"Rheumatology"},{"key":"4_CR88","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1191\/096120301717165010","volume":"10","author":"S.E. Walker","year":"2001","unstructured":"Walker SE (2001) Bromocriptine treatment of systemic lupus erythematosus. Lupus 10:762\u2013728","journal-title":"Lupus"},{"key":"4_CR89","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.coi.2004.03.010","volume":"16","author":"J.G. Monroe","year":"2004","unstructured":"Monroe JG (2004) Ligand-independent tonic signaling in B-cell receptor function. Curr Opin Immunol 16:288\u2013295","journal-title":"Curr Opin Immunol"},{"key":"4_CR90","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H. Wardemann","year":"2003","unstructured":"Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC (2003) Predominant autoantibody production by early human B cell precursors. Science 301:1374\u20131377","journal-title":"Science"},{"key":"4_CR91","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/337562a0","volume":"337","author":"D.A. Nemazee","year":"1989","unstructured":"Nemazee DA, Burki K (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562\u2013566","journal-title":"Nature"},{"key":"4_CR92","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/1074-7613(95)90064-0","volume":"3","author":"C. Chen","year":"1995","unstructured":"Chen C, Nagy Z, Prak EL, Weigert M (1995) Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 3:747\u2013755","journal-title":"Immunity"},{"key":"4_CR93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.179.1.125","volume":"179","author":"D.A. Fulcher","year":"1994","unstructured":"Fulcher DA, Basten A (1994) Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med 179:125\u2013134","journal-title":"J Exp Med"},{"key":"4_CR94","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.177.4.1009","volume":"177","author":"S.L. Tiegs","year":"1993","unstructured":"Tiegs SL, Russell DM, Nemazee D (1993) Receptor editing in self-reactive bone marrow B cells. J Exp Med 177:1009\u20131020","journal-title":"J Exp Med"},{"key":"4_CR95","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1084\/jem.177.4.999","volume":"177","author":"D. Gay","year":"1993","unstructured":"Gay D, Saunders T, Camper S, Weigert M (1993) Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 177:999\u20131008","journal-title":"J Exp Med"},{"key":"4_CR96","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1073\/pnas.89.17.8332","volume":"89","author":"D. Offen","year":"1992","unstructured":"Offen D, Spatz L, Escowitz H, Factor S, Diamond B (1992) Induction of tolerance to an IgG autoantibody. Proc Natl Acad Sci U S A 89:8332\u20138336","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR97","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1073\/pnas.88.24.11550","volume":"88","author":"R.R. Hardy","year":"1991","unstructured":"Hardy RR, Hayakawa K (1991) developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A 88:11550\u201311554","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR98","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1084\/jem.181.6.2129","volume":"181","author":"R. Carsetti","year":"1995","unstructured":"Carsetti R, Kohler G, Lamers MC (1995) Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 181:2129\u20132140","journal-title":"J Exp Med"},{"key":"4_CR99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.190.1.75","volume":"190","author":"F. Loder","year":"1999","unstructured":"Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R, Lamers MC, Carsetti R (1999) B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190:75\u201389","journal-title":"J Exp Med"},{"key":"4_CR100","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.4049\/jimmunol.167.12.6834","volume":"167","author":"D. Allman","year":"2001","unstructured":"Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR (2001) Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 167:6834\u20136840","journal-title":"J Immunol"},{"key":"4_CR101","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.4049\/jimmunol.168.5.2101","volume":"168","author":"T.T. Su","year":"2002","unstructured":"Su TT, Rawlings DJ (2002) Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol 168:2101\u20132110","journal-title":"J Immunol"},{"key":"4_CR102","doi-asserted-by":"crossref","first-page":"48009","DOI":"10.1074\/jbc.M200305200","volume":"277","author":"J.B. Petro","year":"2003","unstructured":"Petro JB, Gerstein RM, Lowe J, Carter RS, Shinners N, Khan WN (2003) Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem 277:48009\u201348019","journal-title":"J Biol Chem"},{"key":"4_CR103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2000.imr017517.x","volume":"175","author":"R.R. Hardy","year":"2000","unstructured":"Hardy RR, Li YS, Allman D, Asano M, Gui M, Hayakawa K (2000) B-cell commitment, development and selection, Immunol Rev 175:23\u201332","journal-title":"Immunol Rev"},{"key":"4_CR104","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ni823","volume":"3","author":"T.T. Su","year":"2002","unstructured":"Su TT, Guo B, Kawakami Y, Sommer K, Chae K, Humphries LA, Kato RM, Kang S, Patrone L, Wall R, Teitell M, Leitges M, Kawakami T, Rawlings DJ (2002) PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 3:780\u2013786","journal-title":"Nat Immunol"},{"key":"4_CR105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80157-0","volume":"12","author":"F. Martin","year":"2000","unstructured":"Martin F, Kearney JF (2000) Selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12:39\u201349","journal-title":"Immunity"},{"key":"4_CR106","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1074-7613(01)00135-2","volume":"14","author":"A. Cariappa","year":"2001","unstructured":"Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, Georgopoulos K, Pillai S (2001) The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603\u2013615","journal-title":"Immunity"},{"key":"4_CR107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ni892","volume":"4","author":"A.N. Anzelon","year":"2003","unstructured":"Anzelon AN, Wu H, Rickert RC (2003) Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 4:287\u2013294","journal-title":"Nat Immunol"},{"key":"4_CR108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.immunol.23.021704.115732","volume":"23","author":"L.J. McHeyzer-Williams","year":"2005","unstructured":"McHeyzer-Williams LJ, McHeyzer-Williams MG (2005) Antigen-specific memory B cell development. Annu Rev Immunol 23:487\u2013513","journal-title":"Annu Rev Immunol"},{"key":"4_CR109","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.20031498","volume":"198","author":"H. Song","year":"2003","unstructured":"Song H, Cerny J (2003) Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J Exp Med 198:1923\u20131935","journal-title":"J Exp Med"},{"key":"4_CR110","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/intimm\/dxh142","volume":"16","author":"A.R. Ferguson","year":"2004","unstructured":"Ferguson AR, Youd ME, Corley RB (2004) Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16:1411\u20131422","journal-title":"Int Immunol"},{"key":"4_CR111","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.4049\/jimmunol.153.8.3551","volume":"153","author":"A. Iliev","year":"1994","unstructured":"Iliev A, Spatz L, Ray S, Diamond B (1994) Lack of allelic exclusion permits autoreactive B cells to escape deletion. J Immunol 153:3551\u20133556","journal-title":"J Immunol"},{"key":"4_CR112","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1073\/pnas.040577497","volume":"97","author":"M.S. Bynoe","year":"2000","unstructured":"Bynoe MS, Grimaldi CM, Diamond B (2000) Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A 97:2703\u20132708","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR113","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.167.4.1886","volume":"167","author":"C.M. Grimaldi","year":"2001","unstructured":"Grimaldi CM, Michael DJ, Diamond B (2001) Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 167:1886\u20131890","journal-title":"J Immunol"},{"key":"4_CR114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1074-7613(00)80471-9","volume":"8","author":"S. Hande","year":"1998","unstructured":"Hande S, Notidis E, Manser T (1998) Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development. Immunity 8:189\u2013198","journal-title":"Immunity"},{"key":"4_CR115","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/MCB.20.8.2890-2901.2000","volume":"20","author":"B. Perillo","year":"2000","unstructured":"Perillo B, Sasso A, Abbondanza C, Palumbo G (2000) 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20:2890\u20132901","journal-title":"Mol Cell Biol"},{"key":"4_CR116","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.174.4.1775","volume":"174","author":"C.M. Grimaldi","year":"2005","unstructured":"Grimaldi CM, Hicks R, Diamond B (2005) B cell selection and susceptibility to autoimmunity. J Immunol 174:1775\u20131781","journal-title":"J Immunol"},{"key":"4_CR117","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI10420","volume":"106","author":"E. Peeva","year":"2002","unstructured":"Peeva E, Grimaldi C, Spatz L, Diamond B (2002) Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 106:1373\u20131379","journal-title":"J Clin Invest"},{"key":"4_CR118","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0753-3322(97)86909-0","volume":"151","author":"M. Neidhart","year":"1997","unstructured":"Neidhart M (1997) Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed Pharmacother 151:118\u2013125","journal-title":"Biomed Pharmacother"},{"key":"4_CR119","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)80554-3","volume":"8","author":"R.J. Cornall","year":"1998","unstructured":"Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497\u2013508","journal-title":"Immunity"},{"key":"4_CR120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","volume":"11","author":"H. Nishimura","year":"1999","unstructured":"Nishimura H, Nose M, Hiai H, Minato N, Honjo T (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11:141\u2013151","journal-title":"Immunity"},{"key":"4_CR121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","volume":"13","author":"S. Bolland","year":"2000","unstructured":"Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma) RIIB-deficient mice results from strain-specific epistasis. Immunity 13:277\u2013285","journal-title":"Immunity"},{"key":"4_CR122","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/sj.gene.6363688","volume":"1","author":"C. Johansson","year":"2000","unstructured":"Johansson C, Castillejo-Lopez C, Johanneson B, Svenungsson E, Gunnarsson I, Frostegard J, Sturfelt G, Truedsson L, Lofstrom B, Alcocer-Varela J, Lundberg I, Gyllensten UB, Alarcon-Segovia D, Alarcon-Riquelme ME (2000) Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families. Genes Immun 1:380\u2013385","journal-title":"Genes Immun"},{"key":"4_CR123","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s100380200062","volume":"47","author":"H. Cao","year":"2002","unstructured":"Cao H, Hegele RA (2002) Identification of polymorphisms in the human SHP1 gene. J Hum Genet 47:445\u2013447","journal-title":"J Hum Genet"},{"key":"4_CR124","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s002510050584","volume":"49","author":"F. Lajaunias","year":"1999","unstructured":"Lajaunias F, Ibnou-Zekri N, Fossati Jimack L, Chicheportiche Y, Parkhouse RM, Mary C, Reininger L, Brighouse G, Izui S (1999) Polymorphisms in the Cd22 gene of inbred mouse strains. Immunogenetics 49:991\u2013995","journal-title":"Immunogenetics"},{"key":"4_CR125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000049039","volume":"90","author":"Z.H. Liu","year":"2002","unstructured":"Liu ZH, Cheng ZH, Gong RJ, Liu H, Liu D, Li LS (2002) Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese. Nephron 90:174\u2013180","journal-title":"Nephron"},{"key":"4_CR126","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/ard.2003.012583","volume":"63","author":"Y.J. Lee","year":"2004","unstructured":"Lee YJ, Shin KS, Kang SW, Lee CK, Yoo B, Cha HS, Koh EM, Yoon SJ, Lee J (2004) Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis 63:1244\u20131249","journal-title":"Ann Rheum Dis"},{"key":"4_CR127","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/ard.2004.032425","volume":"64","author":"M. Johansson","year":"2005","unstructured":"Johansson M, Arlestig L, Moller B, Smedby T, Rantapaa-Dahlqvist S (2005) Estrogen receptor alpha gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis 64:1611\u20131617","journal-title":"Ann Rheum Dis"},{"key":"4_CR128","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K","volume":"44","author":"A. Stevens","year":"2001","unstructured":"Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, Ollier WE, Worthington J, Davis JR (2001) Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum 44:2358\u20132366","journal-title":"Arthritis Rheum"},{"key":"4_CR129","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0198-8859(02)00804-2","volume":"64","author":"M. Mellai","year":"2003","unstructured":"Mellai M, Giordano M, D\u2019Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, Leone M, Ferro I, Liguori M, Trojano M, Ballerini C, Massacesi L, Cannoni S, Bomprezzi R, Momigliano-Richiardi P (2003) Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum Immunol 64:274\u2013284","journal-title":"Hum Immunol"}],"container-title":["Current Topics in Microbiology and Immunology","Current Concepts in Autoimmunity and Chronic Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-29714-6_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T19:48:06Z","timestamp":1683575286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-29714-6_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"ISBN":["9783540297130","9783540297147"],"references-count":129,"URL":"https:\/\/doi.org\/10.1007\/3-540-29714-6_4","relation":{},"ISSN":["0070-217X"],"issn-type":[{"type":"print","value":"0070-217X"}],"subject":[],"published":{"date-parts":[[2006]]}}}